Cancer Immunotherapy Clinical Trials: Patient Perspectives In this webinar designed for patients and caregivers, three cancer survivors share their experiences receiving immunotherapy in a clinical trial and answer viewer questions. Carol Roth, diagnosed in 2015 with stage 4 glioblastoma; Jami Cameron, diagnosed with non-Hodgkin lymphoma in 1994; and Janie Ferling, diagnosed with stage 3 metastatic melanoma in 2013, enrolled in immunotherapy clinical trials that helped them bring cancer back under control. Our 2017 "Cancer Immunotherapy and You" webinar series is made possible with generous support from Genentech, Bristol-Myers Squibb, Advaxis, and Regeneron. Read more: Post navigation Killing Cancer: Immunotherapy for Leukemia and Lymphoma Read Story XVth NIBIT Meeting: Cancer Bio-Immunotherapy in Siena Read Story